Charles Schwab
ATEX icon

Charles Schwab’s Anterix ATEX Stock Holding History

Charles Schwab’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3M Sell
139,278
-2,110
-1% -$124K ﹤0.01% 1983
2026
Q1 		$5.4M Buy
141,388
+2,711
+2% +$85.8K ﹤0.01% 2373
2025
Q4 		$3.03M Buy
138,677
+599
+0.4% +$12.4K ﹤0.01% 2632
2025
Q3 		$2.96M Sell
138,078
-662
-0.5% -$14.8K ﹤0.01% 2655
2025
Q2 		$3.56M Buy
138,740
+7,851
+6% +$230K ﹤0.01% 2473
2025
Q1 		$4.79M Sell
130,889
-3,511
-3% -$121K ﹤0.01% 2290
2024
Q4 		$4.12M Buy
134,400
+1,183
+0.9% +$39.3K ﹤0.01% 2423
2024
Q3 		$5.02M Sell
133,217
-3,157
-2% -$122K ﹤0.01% 2378
2024
Q2 		$5.4M Sell
136,374
-713
-0.5% -$23.1K ﹤0.01% 2328
2024
Q1 		$4.61M Buy
137,087
+2,070
+2% +$69.6K ﹤0.01% 2319
2023
Q4 		$4.5M Buy
135,017
+1,593
+1% +$51.4K ﹤0.01% 2357
2023
Q3 		$4.19M Sell
133,424
-8,094
-6% -$255K ﹤0.01% 2336
2023
Q2 		$4.48M Buy
141,518
+767
+0.5% +$24.8K ﹤0.01% 2276
2023
Q1 		$4.65M Buy
140,751
+3,066
+2% +$100K ﹤0.01% 2240
2022
Q4 		$4.43M Buy
137,685
+2,039
+2% +$69.4K ﹤0.01% 2280
2022
Q3 		$4.85M Buy
135,646
+19,914
+17% +$827K ﹤0.01% 2228
2022
Q2 		$4.75M Sell
115,732
-2,055
-2% -$99.8K ﹤0.01% 2211
2022
Q1 		$6.82M Buy
117,787
+1,985
+2% +$109K ﹤0.01% 2133
2021
Q4 		$6.8M Buy
115,802
+3,694
+3% +$224K ﹤0.01% 2199
2021
Q3 		$6.8M Buy
112,108
+31,852
+40% +$1.87M ﹤0.01% 2229
2021
Q2 		$4.82M Buy
80,256
+2,473
+3% +$124K ﹤0.01% 2373
2021
Q1 		$3.67M Buy
77,783
+2,449
+3% +$101K ﹤0.01% 2444
2020
Q4 		$2.83M Buy
75,334
+1,174
+2% +$38.7K ﹤0.01% 2482
2020
Q3 		$2.43M Sell
74,160
-5,939
-7% -$251K ﹤0.01% 2431
2020
Q2 		$3.63M Buy
80,099
+8,646
+12% +$442K ﹤0.01% 2177
2020
Q1 		$3.26M Buy
71,453
+940
+1% +$42.5K ﹤0.01% 2052
2019
Q4 		$3.05M Buy
70,513
+2,755
+4% +$112K ﹤0.01% 2272
2019
Q3 		$2.45M Buy
67,758
+14,876
+28% +$627K ﹤0.01% 2324
2019
Q2 		$2.49M Sell
52,882
-1,017
-2% -$43K ﹤0.01% 2295
2019
Q1 		$1.9M Buy
53,899
+2,051
+4% +$80.6K ﹤0.01% 2378
2018
Q4 		$1.94M Buy
51,848
+477
+0.9% +$18.6K ﹤0.01% 2344
2018
Q3 		$1.74M Buy
51,371
+4,381
+9% +$128K ﹤0.01% 2468
2018
Q2 		$1.17M Buy
46,990
+2,965
+7% +$82.6K ﹤0.01% 2542
2018
Q1 		$1.31M Buy
44,025
+3,787
+9% +$127K ﹤0.01% 2441
2017
Q4 		$1.29M Buy
40,238
+4,472
+13% +$144K ﹤0.01% 2445
2017
Q3 		$1.07M Buy
35,766
+1,914
+6% +$52.4K ﹤0.01% 2491
2017
Q2 		$789K Buy
33,852
+209
+0.6% +$4.86K ﹤0.01% 2542
2017
Q1 		$736K Buy
33,643
+1,881
+6% +$42.5K ﹤0.01% 2524
2016
Q4 		$717K Buy
31,762
+1,694
+6% +$40.9K ﹤0.01% 2537
2016
Q3 		$689K Buy
30,068
+1,370
+5% +$30.6K ﹤0.01% 2510
2016
Q2 		$614K Sell
28,698
-6,780
-19% -$214K ﹤0.01% 2519
2016
Q1 		$1.22M Buy
35,478
+510
+1% +$13.5K ﹤0.01% 2261
2015
Q4 		$962K Buy
34,968
+5,350
+18% +$146K ﹤0.01% 2407
2015
Q3 		$886K Sell
29,618
-2,015
-6% -$66K ﹤0.01% 2430
2015
Q2 		$1.33M Buy
31,633
+21,203
+203% +$1M ﹤0.01% 2287
2015
Q1 		$522K Buy
+10,430
New +$507K ﹤0.01% 2612

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PM
Plustick Management Charlottesville, Virginia $269M AUM 340.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

Charles Schwab's ATEX Position: Q2 2026 in Review

Charles Schwab reduced its Anterix (ATEX) stake by 1.5% in Q2 2026, selling an estimated $124K and leaving 139,278 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1983.

Charles Schwab first reported a position in ATEX in Q1 2015 and has held it in 46 quarters since. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Charles Schwab held 139,278 shares of Anterix worth $14.3M as of Q2 2026.
  • Charles Schwab sold 2,110 Anterix shares in Q2 2026, an estimated $124K.
  • Anterix made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #1983 holding.
  • Charles Schwab first reported a position in Anterix in Q1 2015 and has held it in 46 quarters since.
  • 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.